BSE Ltd
NSE:BSE
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
BSE Ltd
Cash Equivalents
BSE Ltd
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BSE Ltd
NSE:BSE
|
Cash Equivalents
â‚ą45.4B
|
CAGR 3-Years
41%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Indian Energy Exchange Ltd
NSE:IEX
|
Cash Equivalents
â‚ą1.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
ICRA Ltd
NSE:ICRA
|
Cash Equivalents
â‚ą1.6B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
14%
|
|
Multi Commodity Exchange of India Ltd
NSE:MCX
|
Cash Equivalents
â‚ą7.9B
|
CAGR 3-Years
26%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
CARE Ratings Ltd
NSE:CARERATING
|
Cash Equivalents
â‚ą583.8m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
CRISIL Ltd
NSE:CRISIL
|
Cash Equivalents
â‚ą3.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
7%
|
See Also
What is BSE Ltd's Cash Equivalents?
Cash Equivalents
45.4B
INR
Based on the financial report for Mar 31, 2024, BSE Ltd's Cash Equivalents amounts to 45.4B INR.
What is BSE Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
33%
Over the last year, the Cash Equivalents growth was 75%. The average annual Cash Equivalents growth rates for BSE Ltd have been 41% over the past three years , 33% over the past five years .